Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong
· Delayed Price · Currency is HKD 33.05
-0.95 (-2.79%)
Apr 3, 2025, 4:08 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 17.96 billion as of April 4, 2025. Its market cap has increased by 143.73% in one year.
Market Cap
17.96B
Enterprise Value
20.98B
Revenue
6.09B
Ranking
n/a
PE Ratio
20.57
Stock Price
33.05
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has decreased from 26.66B to 17.96B, a decrease of -32.62%. That is a compound annual growth rate of -6.90%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 227.71B |
| Hansoh Pharmaceutical Group Company | 145.09B |
| WuXi Biologics | 109.81B |
| JD Health International | 105.43B |
| Innovent Biologics | 80.03B |
| Akeso | 77.19B |
| Alibaba Health Information Technology | 76.07B |
| Sino Biopharmaceutical | 69.02B |